Importantly, TRPM7 mediated calcium signals further modulate EMT in breast cancer cells, which TRPM7 deficiency specifically reduces EGF-induced STAT3 phosphorylation and the expression of Vimentin, suggesting that TRPM7 is required for maintaining a mesenchymal feature in breast cancer cells (110). This evidence concerns the gene EGF and breast cancer.